Therapeutics

Latest Innovations

An Epitope and Structure-based Shigella MEFA (multiepitope fusion antigen) Protein Induces Broad Antibody Responses Against Shigella spp

Dr. Zhang from the University of Illinois has developed a promising candidate protein for a vaccine against Shigellosis, an infectious gastrointestinal disease caused by...

Fusidic Acid Derivatives with New Antibacterial Activity

Dr. Paul Hergenrother fhas developed a new series of broad spectrum fusidic acid derivatives. Designed using two distinct methodologies, these fusidic acid derivatives...

Split Prime Editing Platforms

Dr. Pablo Perez-Pinera has developed a method to divide prime editing tools into smaller components that are small enough to be delivered in adeno-associated viruses, an...

Nanobubbles and Their Use in Treating Hypoxia

This new class of nanobubbles for the treatment of hypoxia are comprised of FDA approved compounds and provide a biocompatible environment for incorporating pharmaceutical...

A Multivalent Cholera Multiepitope Fusion Antigen (MEFA) and Application for Development of Effective Vaccines for Cholera

 

Dr. Zhang from the University of Illinois has developed a promising candidate protein for a vaccine against cholera. Cholera is an acute, diarrheal illness caused...

Chimeric Secretory IgA

Professor Beth Stadtmueller and Sonya Kumar Bharathkar have created a chimeric secretory immunoglobulin A (cSIgA) with a modified secretory component (SC) that can be used...

Pages